Cargando…

Protein translation controlled by the androgen receptor in prostate cancer: a novel therapeutic option?

Detalles Bibliográficos
Autores principales:	Mirzakhani, Kimia, Baniahmad, Aria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797708/ https://www.ncbi.nlm.nih.gov/pubmed/35117576 http://dx.doi.org/10.21037/tcr.2020.02.31

Ejemplares similares

Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
por: Kokal, Miriam, et al.
Publicado: (2020)

Androgen-Induced MIG6 Regulates Phosphorylation of Retinoblastoma Protein and AKT to Counteract Non-Genomic AR Signaling in Prostate Cancer Cells
por: Schomann, Tim, et al.
Publicado: (2022)

The androgen receptor—lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells
por: Mirzakhani, Kimia, et al.
Publicado: (2021)

Correction to: The androgen receptor—lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells
por: Mirzakhani, Kimia, et al.
Publicado: (2021)

Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
por: Ehsani, Marzieh, et al.
Publicado: (2021)

ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer
por: Melekhova, Anna, et al.
Publicado: (2021)

Androgen receptor agonist and antagonist reduce response of cytokine‐induced killer cells on prostate cancer cells
por: Pungsrinont, Thanakorn, et al.
Publicado: (2023)

Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
por: Perner, Sven, et al.
Publicado: (2015)

Interaction between Non-Coding RNAs and Androgen Receptor with an Especial Focus on Prostate Cancer
por: Taheri, Mohammad, et al.
Publicado: (2021)

A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant Homeodomain and Regulates Epithelial–Mesenchymal Transition in Prostate Cancer Cells
por: Melekhova, Anna, et al.
Publicado: (2021)

Towards understanding androgen receptor-independent prostate cancer: an evolving paradigm
por: Zhou, Jianfu, et al.
Publicado: (2020)

Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors
por: Bartsch, Sophie, et al.
Publicado: (2021)

Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer
por: Chinni, Sreenivasa R.
Publicado: (2021)

Interleukin-23 Represses the Level of Cell Senescence Induced by the Androgen Receptor Antagonists Enzalutamide and Darolutamide in Castration-Resistant Prostate Cancer Cells
por: Gupta, Siddharth, et al.
Publicado: (2020)

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?
por: Peinetti, Nahuel, et al.
Publicado: (2022)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells
por: Pungsrinont, Thanakorn, et al.
Publicado: (2020)

Androgen receptor splice variant 7 in castration resistant prostate cancer treated with hormonal therapy: what is in the pipeline?
por: Chirra, Martina, et al.
Publicado: (2019)

A phosphorylation switch controls androgen biosynthesis in prostate cancer
por: Qiu, Yun
Publicado: (2023)

Editorial: Epigenetics in prostate cancer
por: Baniahmad, Aria, et al.
Publicado: (2023)

Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Hussein, Mohamed Ali, et al.
Publicado: (2023)

Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target
por: Asim, Mohammad, et al.
Publicado: (2015)

Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016)

Effects of androgen deprivation therapy duration and Gleason grade on survival outcomes of high risk prostate cancer
por: Kim, Do Kyung, et al.
Publicado: (2019)

Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer
por: Nagano, Tatsuya, et al.
Publicado: (2020)

Androgen resistance in prostate cancer
por: Waxman, J, et al.
Publicado: (2008)

Biomarkers of Response to Neoadjuvant Androgen Deprivation in Localised Prostate Cancer
por: Pechlivanis, Maree, et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Jacob, Aasems, et al.
Publicado: (2021)

Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway
por: Roediger, Julia, et al.
Publicado: (2014)

Statins and adrenal androgen levels in prostate cancer: A new twist
por: Mostaghel, Elahe A
Publicado: (2021)

A review on the role of long non-coding RNA prostate androgen-regulated transcript 1 (PART1) in the etiology of different disorders
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2023)

Destroying the androgen receptor (AR)-potential strategy to treat advanced prostate cancer
por: Narayanan, Ramesh, et al.
Publicado: (2017)

Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers
por: Olivari, Alessandro, et al.
Publicado: (2023)

Lenvatinib in elderly hepatocellular carcinoma patients, a new therapeutic option in first line
por: Roth, Gael S., et al.
Publicado: (2020)

Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
por: Asim, Mohammad, et al.
Publicado: (2017)

LncRNA/miRNA/mRNA Network Introduces Novel Biomarkers in Prostate Cancer
por: Taheri, Mohammad, et al.
Publicado: (2022)

Abiraterone acetate, an inhibitor of adrenal androgen synthesis in “hormone refractory prostate cancer”
por: Goel, Arun Kumar, et al.
Publicado: (2011)

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity
por: Siciliano, Tiziana, et al.
Publicado: (2022)

Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer
por: Pungsrinont, Thanakorn, et al.
Publicado: (2021)

Luteolin as a therapeutic option for multiple sclerosis
por: Theoharides, Theoharis C
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_e4unjdmpmkg1lrru6osvk1hg3i